Obesity-induced CerS6-dependent C16:0 ceramide production promotes weight gain and glucose intolerance.
Cell Metab
; 20(4): 678-86, 2014 Oct 07.
Article
em En
| MEDLINE
| ID: mdl-25295788
ABSTRACT
Ceramides increase during obesity and promote insulin resistance. Ceramides vary in acyl-chain lengths from C140 to C300 and are synthesized by six ceramide synthase enzymes (CerS1-6). It remains unresolved whether obesity-associated alterations of specific CerSs and their defined acyl-chain length ceramides contribute to the manifestation of metabolic diseases. Here we reveal that CERS6 mRNA expression and C160 ceramides are elevated in adipose tissue of obese humans, and increased CERS6 expression correlates with insulin resistance. Conversely, CerS6-deficient (CerS6(Δ/Δ)) mice exhibit reduced C160 ceramides and are protected from high-fat-diet-induced obesity and glucose intolerance. CerS6 deletion increases energy expenditure and improves glucose tolerance, not only in CerS6(Δ/Δ) mice, but also in brown adipose tissue- (CerS6(ΔBAT)) and liver-specific (CerS6(ΔLIVER)) CerS6 knockout mice. CerS6 deficiency increases lipid utilization in BAT and liver. These experiments highlight CerS6 inhibition as a specific approach for the treatment of obesity and type 2 diabetes mellitus, circumventing the side effects of global ceramide synthesis inhibition.
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Ceramidas
/
Intolerância à Glucose
/
Esfingosina N-Aciltransferase
Limite:
Animals
/
Female
/
Humans
/
Male
Idioma:
En
Revista:
Cell Metab
Ano de publicação:
2014
Tipo de documento:
Article